The mean of analysts' price targets for Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) points to a 26.5% upside in the stock.

The consensus price target hints at a 108.5% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Copart (NASDAQ:CPRT) is scheduled to announce its earnings in the next week. The company currently holds a market capitalization of $40 billion.

Yann LeCun, 65, a Turing Award-winner considered a pioneer in AI development, has told colleagues he will leave Meta in the coming months, according to a report.

MercadoLibre is a dominant Latin American e-commerce and fintech leader, delivering rapid growth across online shopping, payments, shipping, and credit. MELI posted nearly 40% year-over-year revenue growth in FQ3 2025, with strong gains in gross merchandise value and unique active buyers. Despite a bottom-line miss, MELI's premium valuation is justified by its high double-digit growth and operational excellence across major markets.

Revolution Medicines, Inc. ( RVMD ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 9:00 AM EST Company Participants Mark Goldsmith - CEO, President & Chairman Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division All right. So we'll get started right away.

Natural Gas Services Group, Inc. ( NGS ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Anna Delgado - Investor Relations Coordinator Justin Jacobs - CEO & Director Ian Eckert - Chief Financial Officer Conference Call Participants Selman Akyol - Stifel, Nicolaus & Company, Incorporated, Research Division Tate Sullivan - Maxim Group LLC, Research Division Robert Brown - Lake Street Capital Markets, LLC, Research Division Nate Pendleton James Rollyson - Raymond James & Associates, Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Natural Gas Services Group, Inc. Quarter 3 Earnings …

Xtant Medical Holdings, Inc. ( XTNT ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Sean Browne - President, CEO & Director Scott Neils - Chief Financial Officer Conference Call Participants Kevin Gardner Ryan Zimmerman - BTIG, LLC, Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good morning, everyone, and welcome to the Xtant Medical Third Quarter 2025 Financial Results. [Operator Instructions].

Bain Capital Specialty Finance, Inc. ( BCSF ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Katherine Schneider - MD of Investor Relations & Secretary Michael Ewald - CEO & Director Michael Boyle - President & Director Amit Joshi - Chief Financial Officer Conference Call Participants Finian O'Shea - Wells Fargo Securities, LLC, Research Division Paul Johnson - Keefe, Bruyette, & Woods, Inc., Research Division Presentation Operator Good day, everyone, and welcome to today's Bain Capital Specialty Finance Third Quarter Ended September 30, 2025 Earnings Conference Call. [Operator Instructions] Please note today's call will be recorded, …

Ambac Financial Group, Inc. ( AMBC ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Karen Beyer - MD & Head of Investor Relations Claude LeBlanc - President, CEO & Director David Trick - Executive VP, CFO & Treasurer Conference Call Participants Mark Hughes - Truist Securities, Inc., Research Division Presentation Operator Ladies and gentlemen, good morning, and welcome to the Octave Specialty Group's Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 15, 2025.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.